NEWS

Health

MSD’s legacy of antimicrobial innovation and action

Category: Business News

Delivering on our commitment to fight infectious diseases for more than a century. For more than 100 years, MSD has contributed to the discovery and development of novel medicines and vaccines to fight infectious diseases. With the growing burden of antimicrobial resistance (AMR), we’ve focused on stopping the increasing threat of AMR.  Read full article here.

Source: MSD


More

A roadmap for the health industry

Category: Business News

How will Norway commercialise research and turn health into a green export success? The roadmap for the health industry was released today by Ingvild Kjerkol, Minister of Health and Care Services, and Jan Christian Vestre, Minister of Industry, Trade and Fisheries. The roadmap includes 12 focus areas and 41 actions, which the two ministries have worked […]

Source: Oslo Cancer Cluster


More

Pfizer Invests $43 Billion to Battle Cancer

Category: Business News

NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise […]

Source: Pfizer


More

GE Healthcare Debuts on Nasdaq and Enters S&P 500

Category: Business News

General Electric’s healthcare unit is ready to begin its solo flight on the bourses. In November 2021, the industrial giant decided to break up into three parts. Its healthcare unit, comprising medical technology, pharmaceutical diagnostics, and digital solutions, starts trading on the Nasdaq under the ticker GEHC tomorrow (Jan. 4). The healthcare unit is the […]

Source: Quartz


More

GE Healthcare satser stort i Norge

Category: Business News

Norges største farmasøytiske bedrift, GE Healthcare, gjør investeringer til en verdi av 800 millioner kroner i fabrikken i Lindesnes. Det er for å utvide produksjonskapasitet for legemiddelsubststansen iohexol som brukes i jodholdige kontrastmidler. Den 450 mål store tomten hvor Lindesnes-fabrikken er lokalisert, har vært i drift siden 1974 og har i dag over 450 arbeidsplasser. […]

Source: Healthtalk


More
Page 2 of 12
1 2 3 4 5 12